SiteOne Therapeutics, Inc. clinical trials
Acquired by Eli Lilly and Company, Jul 2025 · source ↗
The registry lists 1 studies whose lead sponsor is SiteOne Therapeutics, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 3, 2023.
- 1study on the registry
- 0open to participants now
Before and after it joined Eli Lilly and Company
- First submitted before SiteOne Therapeutics, Inc. became part of Eli Lilly and Company
- 1
- First submitted after SiteOne Therapeutics, Inc. became part of Eli Lilly and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Stopped early1100%
Over the years
- 121
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- SiteOne Therapeutics, Inc.1 study
Something wrong with this grouping? Tell us on the Eli Lilly and Company page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Eli Lilly and Company studies →
- Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427TerminatedNCT04475198Phase 1
Sponsor listed in the registry: SiteOne Therapeutics, Inc. · First submitted before SiteOne Therapeutics, Inc. became part of Eli Lilly and Company